Intracellular adenosine inhibits IgE-dependent degranulation of human skin mast cells

Journal of Clinical Immunology

Volumn 33, Issue 8, 2013, Pages 1349-1359

  Gomez, Gregorio ^a   Nardone, Vincent ^b   Lotfi Emran, Sahar ^b   Zhao, Wei ^c   Schwartz, Lawrence B ^b  

^a UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^c VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adenosine; adenosine receptors; degranulation; equilibrative nucleoside transporter; mast cells; syk

Indexed keywords

4 [2 [7 AMINO 2 (2 FURYL) 1,2,4 TRIAZOLO[2,3 A][1,3,5]TRIAZIN 5 YLAMINO]ETHYL]PHENOL; ADENOSINE; ADENOSINE A2A RECEPTOR; CALCIMYCIN; COMPLEMENT COMPONENT C5A; DIPYRIDAMOLE; EQUILIBRATIVE NUCLEOSIDE TRANSPORTER 1; IMMUNOGLOBULIN E RECEPTOR; NITROBENZYLTHIOINOSINE; PROTEIN KINASE SYK; SUBSTANCE P;

ARTICLE; CELL ASSAY; CELL FUNCTION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; MAST CELL DEGRANULATION; NUCLEIC ACID ANALYSIS; PRIORITY JOURNAL; PROTEIN CROSS LINKING; PROTEIN FUNCTION; PROTEIN TARGETING; WESTERN BLOTTING;

ADENOSINE; CELL DEGRANULATION; CELLS, CULTURED; DOWN-REGULATION; DRUG SYNERGISM; HUMANS; IMMUNOGLOBULIN E; INTRACELLULAR FLUID; MAST CELLS; NUCLEOSIDE TRANSPORT PROTEINS; RECEPTORS, IGE; SIGNAL TRANSDUCTION; SKIN;

EID: 84889009536     PISSN: 02719142     EISSN: 15732592     Source Type: Journal    
DOI: 10.1007/s10875-013-9950-x     Document Type: Article

References (42)

1. Yegutkin GG. Nucleotide- and nucleoside-converting ectoenzymes: important modulators of purinergic signalling cascade. Biochim Biophys Acta. 2008;1783(5):673-94.
2. Sitkovsky MV, Lukashev D, Apasov S, Kojima H, Koshiba M, Caldwell C, et al. Physiological control of immune response and inflammatory tissue damage by hypoxia-inducible factors and adenosine A2A receptors. Annu Rev Immunol. 2004;22:657-82.
3. Martin C, Leone M, Viviand X, Ayem ML, Guieu R. High adenosine plasma concentration as a prognostic index for outcome in patients with septic shock. Crit Care Med. 2000;28(9):3198-202.
4. Huang L-F, Guo F-Q, Liang Y-Z, Li B-Y, Cheng B-M. Simple and rapid determination of adenosine in human synovial fluid with high performance liquid chromatography-mass spectrometry. J Pharm Biomed Anal. 2004;36(4):877-82.
5. Sottofattori E, Anzaldi M, Ottonello L. HPLC determination of adenosine in human synovial fluid. J Pharm Biomed Anal. 2001;24(5-6):1143-6.
6. Driver AG, Kukoly CA, Ali S, Mustafa SJ. Adenosine in bronchoalveolar lavage fluid in asthma. Am Rev Respir Dis. 1993;148(1):91-7.
7. Molina-Arcas M, Casado FJ, Pastor-Anglada M. Nucleoside transporter proteins. Curr Vasc Pharmacol. 2009;7(4):426-34.
8. Young JD, Yao SYM, Sun L, Cass CE, Baldwin SA. Human equilibrative nucleoside transporter (ENT) family of nucleoside and nucleobase transporter proteins. Xenobiotica. 2008;38(7-8):995-1021.
9. Fredholm BB, IJzerman AP, Jacobson KA, Klotz KN, Linden J. International union of pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol Rev. 2001;53(4):527-52.
10. Marquardt DL, Parker CW, Sullivan TJ. Potentiation of mast cell mediator release by adenosine. J Immunol. 1978;120(3):871-8.
11. Gomez G, Zhao W, Schwartz LB. Disparity in FcεRI-induced degranulation of primary human lung and skin mast cells exposed to adenosine. J Clin Immunol. 2011;31(3):479-87.
12. Peachell PT, Columbo M, Kagey-Sobotka A, Lichtenstein LM, Marone G. Adenosine potentiates mediator release from human lung mast cells. Am Rev Respir Dis. 1988;138(5):1143-51.
13. Peters SP, Schulman ES, Schleimer RP, MacGlashan DW, Newball HH, Lichtenstein LM. Dispersed human lung mast cells. Pharmacologic aspects and comparison with human lung tissue fragments. Am Rev Respir Dis. 1982;126(6):1034-9.
14. Duffy SM, Cruse G, Brightling CE, Bradding P. Adenosine closes the K+ channel KCa3.1 in human lung mast cells and inhibits their migration via the adenosine A2A receptor. Eur J Immunol. 2007;37(6):1653-62.
15. Hillyard PA, Nials AT, Skidmore IF, Vardey CJ. Characterization of the adenosine receptor responsible for the inhibition of histamine and SRS-A release from human lung fragments. Br J Pharmacol. 1984;83(2):337-45.
16. Cushley MJ, Tattersfield AE, Holgate ST. Inhaled adenosine and guanosine on airway resistance in normal and asthmatic subjects. Br J Clin Pharmacol. 1983;15(2):161-5.
17. Drake I, Routledge PA, Richards R. Bronchospasm induced by intravenous adenosine. Hum Exp Toxicol. 1994;13(4):263-5.
18. Ramkumar V, Stiles GL, Beaven MA, Ali H. The A3 adenosine receptor is the unique adenosine receptor which facilitates release of allergic mediators in mast cells. J Biol Chem. 1993;268(23):16887-90.
19. Salvatore CA, Tilley SL, Latour AM, Fletcher DS, Koller BH, Jacobson MA. Disruption of the A(3) adenosine receptor gene in mice and its effect on stimulated inflammatory cells. J Biol Chem. 2000;275(6):4429-34.
20. Hua X, Chason KD, Fredholm BB, Deshpande DA, Penn RB, Tilley SL. Adenosine induces airway hyperresponsiveness through activation of A3 receptors on mast cells. J Allergy Clin Immunol. 2008;122(1):107-13.
21. Suzuki H, Takei M, Nakahata T, Fukamachi H. Inhibitory effect of adenosine on degranulation of human cultured mast cells upon cross-linking of Fc epsilon RI. Biochem Biophys Res Commun. 1998;242(3):697-702.
22. Riske F, Hakimi J, Mallamaci M, Griffin M, Pilson B, Tobkes N, et al. High affinity human IgE receptor (Fc epsilon RI). Analysis of functional domains of the alpha-subunit with monoclonal antibodies. J Biol Chem. 1991;266(17):11245-51.
23. Schwartz LB, Austen KF, Wasserman SI. Immunologic release of beta-hexosaminidase and beta-glucuronidase from purified rat serosal mast cells. J Immunol. 1979;123(4):1445-50.
24. Hughes PJ, Holgate ST, Church MK. Adenosine inhibits and potentiates IgE-dependent histamine release from human lung mast cells by an A2-purinoceptor mediated mechanism. Biochem Pharmacol. 1984;33(23):3847-52.
25. Church MK, Hughes PJ, Vardey CJ. Studies on the receptor mediating cyclic AMP-independent enhancement by adenosine of IgE-dependent mediator release from rat mast cells. Br J Pharmacol. 1986;87(1):233-42.
26. Ali H, Panettieri RA. Anaphylatoxin C3a receptors in asthma. Respir Res. 2005;6:19.
27. Oskeritzian CA, Zhao W, Min H-K, Xia H-Z, Pozez A, Kiev J, et al. Surface CD88 functionally distinguishes the MCTC from the MCT type of human lung mast cell. J Allergy Clin Immunol. 2005;115(6):1162-8.
28. Church MK. el-Lati S, Caulfield JP. Neuropeptide-induced secretion from human skin mast cells. Int Arch Allergy Appl Immunol. 1991;94(1-4):310-8.
29. Behrendt H, Rosenkranz U, Schmutzler W. Ultrastructure of isolated human mast cells during histamine release induced by ionophore A 23187. Int Arch Allergy Appl Immunol. 1978;56(2):188-92.
30. Costello PS, Turner M, Walters AE, Cunningham CN, Bauer PH, Downward J, et al. Critical role for the tyrosine kinase Syk in signalling through the high affinity IgE receptor of mast cells. Oncogene. 1996;13(12):2595-605.
31. Zhang J, Berenstein EH, Evans RL, Siraganian RP. Transfection of Syk protein tyrosine kinase reconstitutes high affinity IgE receptor-mediated degranulation in a Syk-negative variant of rat basophilic leukemia RBL-2H3 cells. J Exp Med. 1996;184(1):71-9.
32. Siraganian RP, Zhang J, Suzuki K, Sada K. Protein tyrosine kinase Syk in mast cell signaling. Mol Immunol. 2002;38(16-18):1229-33.
33. Hughes PJ, Benyon RC, Church MK. Adenosine inhibits immunoglobulin E-dependent histamine secretion from human basophil leukocytes by two independent mechanisms. J Pharmacol Exp Ther. 1987;242(3):1064-70.
34. Rivera J, Fierro NA, Olivera A, Suzuki R. New insights on mast cell activation via the high affinity receptor for IgE. Adv Immunol. 2008;98:85-120.
35. Daëron M, Sterk AR, Hirata F, Ishizaka T. Biochemical analysis of glucocorticoid-induced inhibition of IgE-mediated histamine release from mouse mast cells. J Immunol. 1982;129(3):1212-8.
36. Garcia R, Sastre J, Lauzurica P, Tricas L, Gurbindo C, Lahoz C. Transmethylation reactions in human basophils induced by anti-IgE or specific antigen. Int Arch Allergy Appl Immunol. 1984;73(3):237-41.
37. Ishizaka T, Hirata F, Ishizaka K, Axelrod J. Stimulation of phospholipid methylation, Ca2+ influx, and histamine release by bridging of IgE receptors on rat mast cells. Proc Natl Acad Sci U S A. 1980;77(4):1903-6.
38. Ishizaka T, Conrad DH, Schulman ES, Sterk AR, Ishizaka K. Biochemical analysis of initial triggering events of IgE-mediated histamine release from human lung mast cells. J Immunol. 1983;130(5):2357-62.
39. Ishizaka T, Conrad DH, Huff TF, Metcalfe DD, Stevens RL, Lewis RA. Unique features of human basophilic granulocytes developed in in vitro culture. Int Arch Allergy Appl Immunol. 1985;77(1-2):137-43.
40. Morita Y, Siraganian RP. Inhibition of IgE-mediated histamine release from rat basophilic leukemia cells and rat mast cells by inhibitors of transmethylation. J Immunol. 1981;127(4):1339-44.
41. Sauer AV, Brigida I, Carriglio N, Aiuti A. Autoimmune dysregulation and purine metabolism in adenosine deaminase deficiency. Front Immunol. 2012;3:265.
42. Elford HL, Lin AL. Adenosine deaminase impairment and ribonucleotide reductase in human cells. Ann N Y Acad Sci. 1985;451:98-112.